Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

National Kidney Foundation (NKF) Spring Clinical Meetings 2025

National Kidney Foundation (NKF) Spring Clinical Meetings

Past Event
April 10-13, 2025

Topics: Nephrology

Location: Boston, MA
Type: Hybrid
Booth Info: 1213
Share:
Home » Meetings & Events » NKF 2025

The Spring Clinical Meetings (SCM) is the premiere educational event presented by the National Kidney Foundation (NKF). The event is designed for interprofessional kidney health teams.

Travere at NKF 2025

Travere Therapeutics was excited to participate in the event and engage with renal healthcare professionals.
We look forward to seeing you next year.

Program


Thursday to Saturday, April 10-12

Nephrology

Sparsentan (SPAR) as First-Line Treatment of Incident Patients with IgA Nephropathy (IgAN): Interim Analysis of the SPARTAN Trial

Speakers:
Chee Kay Chung, Stephanie Mood, Neeraj Dhaun, Siân Griffin, Alexandra Howson, Radko Komers, Alex Mercer, Matthew Sayer, Smeeta Sinha, Lisa Willicocks, Jonathan Barratt

Type: Poster

Time:
Thursday – 5:15 PM to 7:30 PM (Poster Q&A)
Friday – 7:00 AM to 8:30 AM,
11:45 AM to 2:00 PM,
5:30 PM to 7:00 PM
Saturday – 7:00 AM to 10:00 AM

Visual summary and presentation: View
Travere MSLs

Meet a Travere MSL

Our Medical Science Liaisons (MSLs) are available to answer questions and provide support on Travere products.

Schedule a meeting
Nephrology

Improving Proteinuria with Sparsentan (SPAR) in Patients (Pts) with IgA Nephropathy (IgAN): A Case Series

Speakers:
Ray R. Goshtaseb, Mrinalini Sarkar, Bijin Thajudeen, K Edmund Tse, Agnes P. Block, Shadi Oweis

Type: Poster

Time:
Thursday – 5:15 PM to 7:30 PM (Poster Q&A)
Friday – 7:00 AM to 8:30 AM,
11:45 AM to 2:00 PM,
5:30 PM to 7:00 PM
Saturday – 7:00 AM to 10:00 AM

Summary and poster: View
Nephrology

Patients (Pts) in DUPLEX Achieved Partial or Complete Remission of Proteinuria Earlier and More Often With Sparsentan (SPAR) vs Irbesartan (IRB): Implications for Slowing Progression to Kidney Failure (KF) in Focal Segmental Glomerulosclerosis (FSGS)

Speakers: James Tumlin, Vladimir Tesar, Hernán Trimarchi, Laura Kooienga, Radko Komers, Jula Inrig, Edward Murphy, Eva Rodriguez

Type: Presentation

Visual summary and presentation: View
Visual abstract: View

MA-DS-25-0001 | February 2025